Commentary Open Access
Volume 3 | Issue 1 | DOI: https://doi.org/10.33696/cardiology.3.031
Commentary on: Echocardiography in Pulmonary Arterial Hypertension: Is It Time to Reconsider Its Prognostic Utility?
Eftychia Demerouti1, Dimitrios Tsiapras1,*
- 1Non Invasive Cardiology Department, Onassis Cardiac Surgery Center, Athens, Greece
Corresponding Author
Dimitrios Tsiapras, dtsiapras@hotmail.com
Received Date: May 24, 2022
Accepted Date: June 16, 2022
Tsiapras D, Demerouti E. Commentary on: Echocardiography in Pulmonary Arterial Hypertension: Is It Time to Reconsider Its Prognostic Utility? J Clin Cardiol. 2022;3(1):29-34.
Copyright: © 2022 Tsiapras D, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Recommended Articles
Commentary on: Echocardiography in Pulmonary Arterial Hypertension: Is It Time to Reconsider Its Prognostic Utility?
Pulmonary Arterial Hypertension (PAH) represents a rare but devastating disease due to small pulmonary arterial vessels remodelling and increased pulmonary vascular resistance leading to right ventricular dysfunction, right heart failure and death.